Third generation cephalosporins in multi-drug resistant typhoid fever.
Gulati
S
S
Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh.
Marwaha
R K
RK
Singhi
S
S
Ayyagari
A
A
Kumar
L
L
D000658:Amoxicillin / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D002702:Chloramphenicol Resistance; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D008297:Male; D012008:Recurrence; D012485:Salmonella typhi / Q000187:drug effects*; D014296:Trimethoprim Resistance; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D002443:Ceftriaxone; D000658:Amoxicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002439:Cefotaxime